autologous 3rd generation CD19-targeting CAR T cell therapy / Uppsala University 
Welcome,         Profile    Billing    Logout  
 15 Diseases   1 Trial   1 Trial   6 News 
1 Trials

   

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
autologous 3rd generation CD19-targeting CAR T cell therapy / Uppsala University
2016-004043-36: T cell therapy for patients with leukemia or lymphoma T cellsterapi för behandling av leukemi och lymfom.

Not yet recruiting
2
25
Europe
3rd generation anti-CD19 CAR T cells, 3rdCARTa19, Solution for infusion
Uppsala University, AFA Insurance AB
CD19+ B cell lymphoma or leukemia CD19+ B cells-malignitet, Leukemia and lymphoma, blood cell cancer Leukemi och lymfom, blodcancer, Diseases [C] - Cancer [C04]
 
 

Download Options